Prot #PCI-32765MCL2003: NU 14H06: A Phase II Clinical Trial Evaluating Ibrutinib Maintenance Following Intensive Induction for Patients with Previously Untreated Mantle Cell Lymphoma (MCL)

Project: Research project

Project Details

StatusActive
Effective start/end date1/6/151/6/21

Funding

  • Janssen Scientific Affairs, LLC (Prot #PCI-32765MCL2003)